Results 291 to 300 of about 75,611 (308)

Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea

Diagnostic Microbiology and Infectious Disease, 2013
In this study, the characteristics of carbapenem-resistant Enterobacteriaceae (CRE) isolates from Korea was investigated. A total of 22 CRE isolates were investigated, and most were identified as Klebsiella pneumoniae (16 isolates). In vitro antimicrobial susceptibility testing, multilocus sequence typing, and pulsed-field gel electrophoresis were ...
So Yeon, Kim, Juyoun, Shin, Sang Yop, Shin, Kwan Soo, Ko   +3 more
openaire   +2 more sources

Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae

Infection Control & Hospital Epidemiology, 2017
OBJECTIVEWe sought to evaluate the role healthcare providers play in carbapenem-resistant Enterobacteriaceae (CRE) acquisition among hospitalized patients.DESIGNA 1:4 case-control study with incidence density sampling.SETTINGAcademic healthcare center with regular CRE perirectal screening in high-risk units.PATIENTSWe included case patients with ≥1 ...
Marika E, Grabowski, Hyojung, Kang, Kristen M, Wells, Costi D, Sifri, Amy J, Mathers, Jennifer M, Lobo   +5 more
openaire   +2 more sources

Carbapenem-Resistant Enterobacteriaceae: A Call for Cultural Change

Annals of Internal Medicine, 2014
Starting in 2011, a cluster of infections caused by carbapenem-resistant Enterobacteriaceae (CRE) occurred at the National Institutes of Health Clinical Center.
Tara N, Palmore, David K, Henderson
openaire   +2 more sources

Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan

Infection Control & Hospital Epidemiology, 2014
Background.Carbapenem-resistant Enterobacteriaceae (CRE) are clinically challenging, threaten patient safety, and represent an emerging public health issue. CRE reporting is not mandated in Michigan.Methods.The Michigan Department of Community Health–led CRE Surveillance and Prevention Initiative enrolled 21 facilities (17 acute care and 4 long-term ...
Brenda M, Brennan, Joseph R, Coyle, Dror, Marchaim, Jason M, Pogue, Martha, Boehme, Jennie, Finks, Anurag N, Malani, Kerrie E, VerLee, Bryan O, Buckley, Noreen, Mollon, Daniel R, Sundin, Laraine L, Washer, Keith S, Kaye   +12 more
openaire   +2 more sources

Carbapenem-resistant Enterobacteriaceae: global action required

The Lancet Infectious Diseases, 2019
Federico, Perez, Robert A, Bonomo
openaire   +2 more sources

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Clinical Microbiology Reviews, 2017
Li Yang Hsu, Anucha Apisarnthanarak, Erum Khan   +2 more
exaly  

Carbapenem-Resistant Enterobacteriaceae

Amália Raiana Fonseca Lobato, Beatriz Lobato da Silva, Artur Silva, Danielle Murici Brasiliense, Rafael Azevedo Baraúna   +4 more
openaire   +1 more source

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Ghady Haidar, Yohei Doi
exaly  

Community-associated Carbapenem-Resistant Enterobacteriaceae

Case Medical Research, 2019
openaire   +1 more source

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections

Antibiotics, 2019
María Teresa Pérez Gracia
exaly